|
KLHL8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.22044604925031E-16 |
| Normal-vs-Stage2 |
3.62529994912819E-09 |
| Normal-vs-Stage3 |
7.7715611723761E-16 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
1.141180E-01 |
| Stage1-vs-Stage3 |
4.448000E-01 |
| Stage1-vs-Stage4 |
1.035930E-04 |
| Stage2-vs-Stage3 |
8.081800E-02 |
| Stage2-vs-Stage4 |
1.821660E-04 |
| Stage3-vs-Stage4 |
1.939830E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.9662000000652E-07 |
| Normal-vs-Asian |
<1E-12 |
| Caucasian-vs-AfricanAmerican |
2.674800E-01 |
| Caucasian-vs-Asian |
1.722000E-01 |
| AfricanAmerican-vs-Asian |
1.271980E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
7.852200E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.11022302462516E-16 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62914126633495E-12 |
| Normal-vs-Age(81-100Yrs) |
5.680400E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.820800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.109600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.002000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.665600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.949000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.224200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.376600E-04 |
| Classical-VS-Follicular |
1.58269999994687E-06 |
| Classical-VS-Other |
4.280300E-02 |
| Classical-VS-Normal |
4.44089209850063E-16 |
| Tall-VS-Follicular |
4.58439952666367E-10 |
| Tall-VS-Other |
9.419400E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.64737999999165E-05 |
| Follicular-VS-Normal |
3.27379999998101E-06 |
| Other-VS-Normal |
3.46299655618054E-11 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
1.62447832963153E-12 |
| N0-vs-N1 |
1.443710E-04 |
|
|
